TABLE 3.

Main limitations reported by clinicians when recommending gastrostomy for patients with atypical parkinsonian syndromes (APS)

Limitations in recommending gastrostomy in APS	Frequency from 38 respondents (%)
Lack of local services offering gastrostomy insertion.	5 (13%)
Lack of local or national care pathways for gastrostomy insertion in APS.	21 (55%)
Decisions/discussion on gastrostomy insertion delayed until advanced stage precluding intervention.	23 (61%)
Lack of supporting evidence on safety, survival and/or quality of life outcomes after gastrostomy insertion.	26 (68%)